Table 6.

Societal-level condition-specific estimates of effects on mean VAS scores based on the best-fitting multivariate model for developed and developing countries

	Developing countries			Developed countries			All countries
	Est	(SE)	Rank	Est	(SE)	Rank	Est	(SE)	Rank
I. Chronic physical conditions
Arthritis	−0.5*	(0.1)	4	−0.8*	(0.1)	3	−0.7*	(0.1)	3
Cancer	−0.0	(0.0)	18	−0.0	(0.0)	19	−0.0	(0.0)	19
Cardiovascular disorders	−0.8*	(0.1)	2	−0.9*	(0.1)	2	−0.8*	(0.1)	2
Chronic pain conditions	−1.3*	(0.2)	1	−1.6*	(0.1)	1	−1.6*	(0.1)	1
Diabetes	−0.2*	(0.0)	8	−0.3*	(0.0)	7	−0.3* **	(0.0)	7
Digestive disorders	−0.0	(0.0)	15	−0.2*	(0.0)	9	−0.1* **	(0.0)	9
Headaches or migraines	−0.7*	(0.1)	3	−0.5*	(0.1)	5	−0.6* **	(0.0)	4
Insomnia	−0.2*	(0.0)	6	−0.4*	(0.0)	6	−0.4* **	(0.0)	6
Neurological disorders	−0.1*	(0.0)	10	−0.1*	(0.0)	11	−0.1*	(0.0)	10
Respiratory disorders	−0.2*	(0.1)	7	−0.2*	(0.1)	8	−0.2*	(0.1)	8
II. Mental conditions
Alcohol abuse	−0.1*	(0.0)	9	−0.0*	(0.0)	17	−0.1*	(0.0)	15
Bipolar disorder	−0.0	(0.0)	16	−0.0*	(0.0)	16	−0.0*	(0.0)	17
Drug abuse	−0.0	(0.0)	13	−0.0*	(0.0)	18	−0.0*	(0.0)	18
Generalized anxiety disorder	−0.0	(0.0)	19	−0.1*	(0.0)	13	−0.0* **	(0.0)	16
Major depressive episode	−0.4*	(0.0)	5	−0.5*	(0.0)	4	−0.4* **	(0.0)	5
Panic disorder	−0.1*	(0.0)	11	−0.1*	(0.0)	12	−0.1* **	(0.0)	12
Post-traumatic stress disorder	−0.0	(0.0)	12	−0.1*	(0.0)	14	−0.1*	(0.0)	13
Social phobia	−0.0	(0.0)	14	−0.1*	(0.0)	15	−0.1*	(0.0)	14
Specific phobia	−0.0	(0.0)	17	−0.2*	(0.0)	10	−0.1* **	(0.0)	11
III. Any condition
Physical	−4.4*	(0.2)		−4.6*	(0.2)		−4.6*	(0.2)
Mental	−0.8*	(0.1)		−1.2*	(0.1)		−1.1* **	(0.0)
Any	−5.4*	(0.3)		−5.9*	(0.2)		−5.8*	(0.2)

^*Significant at the 0.05 level, two-sided test

^**Significant difference between developing and developed countries at the 0.05 level, two-sided test